LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Novartis AG Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$764,000
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-10.08%
quarter
Novartis AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.21% | -898 shares | -161K | $76.01 | 10.04K |
| Q2 2022 | share | Decrease | -8.22% | -980 shares | -121K | $84.53 | 10.94K |
| Q1 2022 | share | Increase | +0.42% | 50 shares | 7K | $87.75 | 11.92K |
| Q4 2021 | share | Decrease | -15.35% | -2.15K shares | -108K | $87.46 | 11.87K |
| Q3 2021 | share | Decrease | -11.01% | -1.73K shares | -291K | $81.78 | 14.02K |
| Q2 2021 | share | Increase | +1.27% | 197 shares | 108K | $91.24 | 15.76K |
| Q1 2021 | share | Decrease | -20.12% | -3.92K shares | -510K | $85.48 | 15.56K |
| Q4 2020 | share | Decrease | -7.47% | -1.57K shares | 9K | $90.76 | 19.48K |
| Q3 2020 | share | Decrease | -3.66% | -800 shares | -78K | $83.58 | 21.05K |
| Q2 2020 | share | Increase | +4.65% | 972 shares | 187K | $83.94 | 21.85K |
| Q1 2020 | share | Decrease | -2.75% | -590 shares | -312K | $79.24 | 20.88K |
| Q4 2019 | share | Decrease | -33.60% | -10.86K shares | -776K | $87.81 | 21.47K |
| Q3 2019 | share | Increase | +8.62% | 2.56K shares | 91K | $80.59 | 32.34K |
| Q2 2019 | share | Decrease | -16.04% | -5.68K shares | -690K | $84.68 | 29.77K |
| Q1 2019 | share | Decrease | -10.49% | -4.15K shares | 9K | $89.16 | 35.46K |
| Q4 2018 | share | Decrease | -3.33% | -1.36K shares | -131K | $77.1 | 39.61K |
| Q3 2018 | share | Decrease | -3.94% | -1.68K shares | 308K | $77.42 | 40.98K |
| Q2 2018 | share | Decrease | -23.76% | -13.29K shares | -1.30M | $67.88 | 42.66K |
| Q1 2018 | share | Decrease | -28.60% | -22.41K shares | -2.05M | $72.65 | 55.96K |
| Q4 2017 | share | Decrease | -9.20% | -7.93K shares | -830K | $72.78 | 78.37K |
| Q3 2017 | share | Decrease | -1.59% | -1.39K shares | -63K | $74.42 | 86.31K |
| Q2 2017 | share | Decrease | -4.80% | -4.42K shares | 630K | $72.36 | 87.70K |
| Q1 2017 | share | Decrease | -0.53% | -494 shares | 96K | $64.38 | 92.13K |
| Q4 2016 | share | Decrease | -1.34% | -1.26K shares | -666K | $60.96 | 92.62K |
| Q3 2016 | share | Decrease | -8.05% | -8.22K shares | -1.01M | $66.08 | 93.88K |
| Q2 2016 | share | Decrease | -4.70% | -5.03K shares | 664K | $69.05 | 102.10K |
| Q1 2016 | share | Decrease | -5.01% | -5.65K shares | -1.94M | $60.62 | 107.14K |